Hamamatsu-cho Empress Bldg. 3F, 2-9-6
Hamamatsu-cho, Minato-ku, Tokyo 105-0013, JAPAN
TEL： +81-3-6435-9761
FAX： +81-3-6435-9762
URL：
https://eng.ryumachi-jp.com/
E-mail：
gakkaih@ryumachi-jp.com
Congress Secretariat
c/o Congrès Inc.
Onward Park Bldg., 3-10-5 Nihonbashi, Chuo-ku Tokyo 103-8276, JAPAN
TEL： +81-3-3510-3701
FAX： +81-3-3510-3702
E-mail：support@jcr2024.com
English Session
[As of Mar. 4, 2024]
Thursday, April 18
Friday, April 19
Saturday, April 20
Representative Session
From Housewife to Prime Minister. Reflections on Finland’s Way toward a Gender Equal Society
Friday, April 19 11:00-11:50 Room 1 ( Portopia Hall, 1F, South Building, Kobe Portopia Hotel )
| Chair： | Michiaki Takagi | Department of Orthopaedic Surgery, Yamagata University Faculty of Medicine, Yamagata, Japan |
|---|---|---|
| Speaker： | Nina Santavirta | Faculty of Educational Sciences, University of Helsinki, Finland |
Symposium
S 4
Thursday, April 18 9:30-12:00 Room 11 (International Conference Room, 3F, Kobe International Conference Center)
Recent advances in systemic autoimmune diseases
| Chairs: | Yuko Kaneko | Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Japan |
|---|---|---|
| Peter C. Taylor | Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, UK |
S4-1Management options in "difficult to treat" rheumatoid arthritis
| Peter C. Taylor | Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, UK |
S4-2Advances in systemic lupus erythematosus
| Yoshiya Tanaka | The First Department of internal Medicine, University of Occupational and Environmental Health, Japan |
S4-3Management of interstitial lung disease associated with systemic autoimmune diseases
| Masataka Kuwana | Department of Allergy and Rheumatology, Nippon Medical School Graduate School of Medicine, Japan |
S4-4Update on treatment of ANCA-associated vasculitis
| Bernhard Hellmich | Medius Kliniken, University of Tübingen, Kirchheim-Teck, Germany |
S4-5Still's disease: EULAR / PReS guidelines for the diagnosis and management of Still's disease
| Bruno Fautrel | Sorbonne University / Assistance Publique - Hopitaux de Paris, France |
S 7
Thursday, April 18 14:05-16:35 Room 11 ( International Conference Room, 3F, Kobe International Conference Center )
New insight into the pathogenesis of glucocorticoid-induced osteoporosis
| Chairs: | Takeshi Miyamoto | Department of Orthopedic Surgery, Kumamoto University, Japan |
|---|---|---|
| Kunihiro Yamaoka | Kitasato University School of Medicine, Japan |
S7-1Overview of glucocorticoid-induced osteoporosis
| Yoshiya Tanaka | The First Department of internal Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan |
S7-2Fracture-risks in patients with glucocorticoid-induced osteoporosis
| Mary Beth Humphrey | Department of Medicine, Division of Rheumatology, Immunology, and Allergy, Oklahoma University Health Sciences Center, Oklahoma, USA |
S7-3New Evidence of Bone Safety of Glucocorticoids in the treatment of Inflammatory Rheumatic Diseases
| Kenneth G. Saag | Division of Clinical Immunology and Rheumatology, The University of Alabama at Birmingham, Alabama, USA |
S7-4Surgical treatment and management of glucocorticoid-induced osteoporosis
| Kosuke Ebina | Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine / Department of Musculoskeletal Regenerative Medicine, Osaka University Graduate School of Medicine, Japan |
S7-5Pharmacological treatment of glucocorticoid-induced osteoporosis
| Kunihiro Yamaoka | Department of Rheumatology and Infectious Diseases, Kitasato University School of Medicine, Japan |
S 15
Saturday, April 20 8:40-11:10 Room 11 (International Conference Room, 3F, Kobe International Conference Center)
New insights into pathogenesis of rheumatoid arthritis
| Chairs: | Hiroshi Takayanagi | Department of Immunology, Graduate School of Medicine and Faculty of Medicine, The University of Tokyo, Japan |
|---|---|---|
| George Kollias | Department of Physiology, Medical School, University of Athens, Athens, Greece |
S15-1Synovial Macrophage in Joint Homeostasis and Inflammation
| Gerhard Krönke | Charité, Universitätsmedizin Berlin, Germany |
S15-2Immunogenetics to understand the etiology of autoimmunity
| Kazuyoshi Ishigaki | Laboratory for Human Immunogenetics, RIKEN Center for Integrative Medical Sciences, Japan |
S15-3Fibroblasts as regulators of inflammation and damage in arthritis
| Adam P. Croft | Rheumatology Research Group, University of Birmingham, Birmingham, UK |
S15-4The immune-stromal-bone interaction in autoimmune arthritis
| Noriko Komatsu | Graduate School of Medicine and Faculty of Medicine, The University of Tokyo, Japan |
S15-5FIBROBLAST-DRIVEN PATHOGENIC MECHANISMS IN JOINT/GUT AXIS DISEASES
| George Kollias | Department of Physiology, Medical School, University of Athens, Athens, Greece |
S 19
Saturday, April 20 14:40-16:40 Room 7 ( Kairaku 3, B1, Main Building, Kobe Portopia Hotel )
Young Rheumatologists International Interactive Session
| Chairs: | Masaru Kato | Rheumatology and Nephrology, Hokkaido University Hospital, Japan |
|---|---|---|
| Masayuki Nishide | Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Japan |
S19-1A case of adult-onset Still’s disease with tendonitis and tenosynovitis -including ultrasound assessment-
| Sho Sendo | Department of Clinical Laboratory/ Division of Rheumatology and Clinical Immunology, Kobe university hospital, Japan |
S19-2Developing a EULAR network of early career researchers dedicated to lung diseases in inflammatory rheumatisms.
| Pierre Antoine Juge | Service de Rhumatologie, Hopital Bichat Claude Bernard, Paris, France |
S19-3Modifications of T cell phenotype with TYK2 Inhibitor and its implications for the treatment of Systemic lupus erythematosus (SLE)
| Yurie Satoh Kanda | The 1st Department of Internal Medicine, University of Occupatinal and Environmental Health, Japan |
S19-4From clinical observation to data analysis: a case report on IgG4-related kidney disease and evaluating infection risks of rituximab in anti-neutrophil cytoplasmic antibody-associated vasculitis through network meta-analysis
| Meng-Ko Tsai | Division of Rheumatology, Immunology, and Allergy, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei / Division of Rheumatology, Immunology and Allergy, Department of Internal Medicine, Taichung Armed Forces General Hospital, Taichung / Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei, Taiwan |
S19-5Omics analysis of severe complications of autoimmune diseases
| Wataru Fujii | Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Japan |
S19-6EMEUNET- aspirational goals for a harmonised community
| Latika Gupta | University of Manchester / Royal Wolverhampton NHS Trust, UK |
Special Symposium
SS 2（APLAR Session）
Friday, April 19 8:40-10:40 Room 11 ( International Conference Room, 3F, Kobe International Conference Center )
APLAR activities: recent understandings of important clinical issues and recent translational research investigations
| Chairs: | Tsutomu Takeuchi | Saitama Medical University / Keio University School of Medicine, Japan |
|---|---|---|
| Atsushi Kawakami | Department of Immunology and Rheumatology Division of Advanced Preventive Medical Sciences Nagasaki University Graduate School of Biomedical Sciences, Japan |
SS2-1Musculoskeletal ultrasound for Rheumatic musculoskeletal diseases in resource limited set up
| Farzana Shumy | Square Hospitals LTD Dhaka, Bangladesh |
SS2-2Pregnancy and Rheumatic diseases in APLAR region
| Samar Al Emadi | Division of Rheumatology, Department of Medicine, HMC, Oman |
SS2-3Systemic autoinflammatory disease in adults: diagnostic approach and treatment
| Hugh C. Caterson | Prince of Wales Hospital, Sydney, Australia |
SS2-4Synovial tissue heterogeneity and predominant inflammatory signal in Japanese patients with rheumatoid arthritis.
| Sotaro Nakajima | Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan |
SS2-5Single cell analysis reveals the diversity of rheumatic diseases
| Masayuki Nishide | Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Japan |
SS 3（EULAR Session）
Friday, April 19 15:10-17:10 Room 11( International Conference Room, 3F, Kobe International Conference Center )
EULAR Updates and Perspectives in Rheumatology
| Chairs: | Kunihiro Yamaoka | Kitasato University School of Medicine, Japan |
|---|---|---|
| Yukinori Okada | Department of Genome Informatics, Graduate School of Medicine, the University of Tokyo, Japan |
SS3-1EULAR: past, present, and future
| Daniel Aletaha | Division of Rheumatology, Medical University Vienna, Austria |
SS3-2Imaging and AI in rheumatology
| Annamaria Iagnocco | University of Turin, Italy |
SS3-3Getting the diagnosis right: now and in the future - rheumatoid arthritis as an example
| Gerd R. Burmester | Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin, Berlin, Germany |
SS3-4Management of Psoriatic Arthritis
| Iain B. McInnes | College of Medical, Veterinary & Life Sciences (MVLS), University of Glasgow, Glasgow, United Kingdom |
SS3-5Management of rheumatoid arthritis
| Josef S. Smolen | Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, Austria |
SS 4（ACR Session）
Saturday, April 20 14:30-16:30 Room 11 ( International Conference Room, 3F, Kobe International Conference Center )
System biology and mechanism-based therapy in rheumatic disease
| Chairs: | Yoshiya Tanaka | The First Department of internal Medicine, University of Occupational and Environmental Health, Japan |
|---|---|---|
| Hideto Kameda | Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Toho University, Japan |
SS4-1A Systems Biology Approach to Lupus Nephritis
| Andrea Fava | Division of Rheumatology, Johns Hopkins University, Baltimore, USA |
SS4-2Pathologic Bone Resorption and New Bone Formation in Psoriatic Arthritis and Rheumatoid Arthritis, and Implications for Therapy
| Christopher Ritchlin | Division of Allergy, Immunology and Rheumatology, University of Rochester Medical Center, Rochester, New York, USA |
TREG Session
Saturday, April 20 9:10-11:10 Room 1 ( Portopia Hall, 1F, South Building, Kobe Portopia Hotel )
Conference analysis of ACR 2023 and EULAR 2023
| Chairs: | Yoshiya Tanaka | The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan |
|---|---|---|
| Kei Ikeda | Department of Rheumatology, Dokkyo Medical University, Tochigi, Japan |
TS -1Update from ACR Convergence 2023: Systemic Lupus Erythematosus (SLE) and Autoimmune Rheumatic Disorders
| Allan Gibofsky | Hospital for Special Surgery-Weill Cornell Medicine, NY, USA |
TS -2New molecules in Systemic Lupus Erythematosus (SLE), Rheumatoid Arthritis ( RA), Sjögren's (pSS), Systemic Sclerosis (dSSc) and Behcet's disease (BD) presented at EULAR and ACR 2023
| Roy M. Fleischmann | University of Texas Southwestern Medical Center, Dallas, TX, USA |
TS -3Progress in the Therapeutic Approach to Rheumatoid Arthritis (RA)
| Arthur Kavanaugh | University of California, San Diego. La Jolla, California, USA |
TS -4Review of Spondyloarthritis Abstracts at the November 2023 American College of Rheumatology Meeting
| Christopher Ritchlin | Allergy, Immunology and Rheumatology Division, University of Rochester Medical Center, Rochester, NY, USA |
Educational Lecture
EL 17
Friday, April 19 15:15-16:15 Room 14 (Convention Hall South, 1F, No.2 Building, Kobe International Exhibition Hall)
Osteoarthritis: Current Knowledge and Treatment from the Orthopaedic Surgeon's Perspective
| Chair： | Yasuharu Nakashima | Department of Orthopaedic Surgery, Kyushu University, Japan |
|---|---|---|
| Lecturer： | Stuart B. Goodman | Department of Orthopaedic Surgery, Stanford University, Stanford, CA, USA |
EL 18
Friday, April 19 16:25-17:25 Room 14 ( Convention Hall South, 1F, No.2 Building, Kobe International Exhibition Hall )
Perioperative Risk Mitigation: Guideline for Perioperative Care of the Rheumatic Disease Patient
| Chair： | Michiaki Takagi | Department of Orthopaedic Surgery, Yamagata University Faculty of Medicine, Yamagata, Japan |
|---|---|---|
| Lecturer： | Susan M. Goodman | Hospital for Special Surgery, Weill Cornell Medicine, NYC, USA |
Meet the Expert
MTE 11
Friday, April 19 8:40-9:40 MTE Room 1 ( 401, 4F, Kobe International Conference Center )
Keys to musculoskeletal physical exam
| Lecturer： | Masato Nagao | University of California San Francisco, San Francisco, USA |
|---|
MTE 12
Friday, April 19 9:50-10:50 MTE Room 1 ( 401, 4F, Kobe International Conference Center )
Physical examination of an arthritis or spondyloarthritis patient. The Scandinavian way to perform it
| Lecturer： | Markku J. Kauppi | Faculty of Medicine, Clinicum, Helsinki University, Helsinki / Päijät-Häme Central Hospital, Lahti, Finland |
|---|
Morning Seminar
MS 7
Rheumatoid Arthritis Treatment Updates:
Focus on The Evolution of IL-6 Inhibition Therapy in EULAR Recommendations
April 19 (Fri) 7:30-8:30 Room 12 (Main Hall, 1F, Kobe International Conference Center)
| Chair： | Tsutomu Takeuchi | Saitama Medical University / Keio University |
|---|
2022 Updated EULAR RA Management Recommendations in a Global Perspective
| Speaker： | Josef Smolen | Division of Rheumatology Department of Medicine 3, Medical University of Vienna, Austria |
|---|---|---|
| Sponsored： | CHUGAI PHARMACEUTICAL CO., LTD. | |
MS 13
Upadacitinib 2024: Thoughts on Long Term Safety/Efficacy in RA and Appropriate Use
April 20 (Sat) 7:30-8:30 Room 10 (504+505, 5F, Kobe International Conference Center)
| Chair： | Kei Ikeda | Department of Rheumatology, Dokkyo Medical University |
|---|---|---|
| Speaker： | Roy Fleischmann | Metroplex Clinical Research Center, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, USA |
| Sponsored： | AbbVie GK | |
MS 14
Up-to-date evidence in RA and SpA treatment
April 20 (Sat) 7:30-8:30 Room 11 (International Conference Room, 3F, Kobe International Conference Center)
| Chair： | Hideto Kameda | Division of Rheumatology, Department of Internal Medicine, Toho University |
|---|
MS14-1NEW PARADIGM IN THE TREATMENT OF RA:
EVOLUTION FROM MONOCLONAL ANTIBODIES TO JAK-INHIBITORS - THE NEW ERA
| Speaker： | Gerd R. Burmester | Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin, Berlin, Germany |
|---|
MS14-2Psoriatic and Rheumatoid Arthritis: Distinctive and Overlapping Features
| Speaker： | Christopher Ritchlin | Division of Allergy, Immunology and Rheumatology, University of Rochester Medical Center, Rochester, New York, USA |
|---|---|---|
| Sponsored： | Eli Lilly Japan K.K. | |
Luncheon Seminar
LS 1
Modern management strategies for RA: achieving clinical and structural remission with filgotinib
April 18 (Thu) 12:15-13:15 Room 2 (Ohwada A, 1F, South Building, Kobe Portopia Hotel)
| Chair： | Tsutomu Takeuchi | Saitama Medical University / Keio University |
|---|
| Speaker： | Peter C Taylor | Norman Collisson Professor of Musculoskeletal Sciences, Nuffield Dept. of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford |
|---|---|---|
| Sponsored： | Gilead Sciences K.K. / Eisai co.,Ltd. | |
LS 3
The Role of Interleukin-6 in Rheumatoid Arthritis
April 18 (Thu) 12:15-13:15 Room 4 (Ohwada C, 1F, South Building, Kobe Portopia Hotel)
| Chair： | Yuko Kaneko | Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine |
|---|
| Speaker： | Gerd R. Burmester | Department of Rheumatology and Clinical Immunology Charité – Universitätsmedizin Berlin Freie Universität Berlin and Humboldt-Universität zu Berlin Berlin, Germany |
|---|---|---|
| Sponsored： | ASAHI KASEI PHARMA CORPORATION | |
LS 11
Update on the management of ILD in rheumatic diseases
April 18 (Thu) 12:15-13:15 Room 12 (Main Hall, 1F, Kobe International Conference Center)
| Chair： | Hidekata Yasuoka | Department of Rheumatology, Department of Internal Medicine, Fujita Health University School of Medicine |
|---|
| Speaker： | Anna Maria Hoffmann-Vold | Department of Rheumatology, Oslo University Hospital, Oslo, Norway |
|---|---|---|
| Sponsored： | Nippon Boehringer Ingelheim Co., Ltd. | |
LS 12
Rheum Up to DateーPatient Based Risk Assessment in RA―
April 18 (Thu) 12:05-13:15 Room 13 (Convention Hall North, 1F, No.2 Building, Kobe International Exhibition Hall)
| Chair： | Kunihiro Yamaoka | Department of Rheumatology and Infectious Diseases, Kitasato University School of Medicine |
|---|---|---|
| Iain B. McInnes | University of Glasgow, UK |
LS12-1The future of RA treatment – no more guesswork?
| Speaker： | Iain B. McInnes | University of Glasgow, UK |
|---|
LS12-2Optimization Strategy for Rheumatoid Arthritis Treatment Based on the Latest Recommendations and Evidence
| Speaker： | Kosuke Ebina | Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine |
|---|
LS12-3Management of adverse events associated with JAK inhibitors
| Speaker： | Satoshi Kubo | Department of Molecular Targeted Therapies, School of Medicine, University of Occupational and Environmental Health |
|---|---|---|
| Sponsored： | AbbVie GK | |
LS 14
Clinical significance of IL-23 in the treatment of Psoriatic arthritis
April 18 (Thu) 12:15-13:15 Room 15 (2A Meeting Room, 2F, No.2 Building, Kobe International Exhibition Hall)
| Chair： | Tadashi Okano | Specially Appointed Professor, Center for Senile Degenerative Disorders (CSDD), Osaka Metropolitan University Graduate School of Medicine |
|---|
| Speaker： | Paul Bird | St George Clinical School, University of New South Wales |
|---|---|---|
| Sponsored： | Janssen Pharmaceutical K.K. / Taiho Pharmaceutical Co., Ltd. | |
LS 16
Modernizing the clinical approach to RA management by preventing structural joint damage:
the JAK inhibitor filgotinib
April 19 (Fri) 12:05-13:05 Room 3 (Ohwada B, 1F, South Building, Kobe Portopia Hotel)
| Chair： | Tatsuya Atsumi | Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Japan |
|---|---|---|
| Speaker： | Peter C Taylor | Norman Collisson Professor of Musculoskeletal Sciences, Nuffield Dept. of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford |
| Discussers： | Kei Ikeda | Department of Rheumatology, Dokkyo Medical University, Japan |
| Shuji Asa | Department of Orthopedic Surgery, Nagoya University Graduate School of Medicine, Japan | |
| Tomohiro Koga | Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Japan |
|
| Sponsored： | Gilead Sciences K.K. / Eisai co.,Ltd. | |
Evening Seminar
ES 2
Latest evidence update of a JAK inhibitor drug
April 18 (Thu) 16:45-18:15 Room 5 (Kairaku 1, B1, Main Building, Kobe Portopia Hotel)
| Chair： | Yoshiya Tanaka | The First Department of Internal Medicine, University of Occupational and Environmental Health, Japan |
|---|
ES2-1Recent real-world evidence of baricitinib treatment in patients with rheumatoid arthritis
~ Japanese PMS data and the RA-BE-REAL study ~
| Speaker： | Takao Fujii | Department of Rheumatology and Clinical Immunology, Wakayama Medical University, Japan |
|---|
ES2-2Baricitinib versus TNF-inhibitors in Patients with Rheumatoid Arthritis:
a Pragmatic, Multicenter, Real-Life Study in a Treat-to-Target Setting after failing csDMARDs
| Speaker： | Mart A F J van de Laar | Department Psychology, Health and Technology, University of Twente, The Netherlands |
|---|---|---|
| Sponsored： | Eli Lilly Japan K.K. | |
ES 9
Critical role of IL-6 Inhibition for Autoimmune Diseases
April 19 (Fri) 17:40-19:10 Room 2 (Ohwada A, 1F, South Building, Kobe Portopia Hotel)
| Chair： | Masataka Kuwana | Department of Allergy and Rheumatology, Nippon Medical School, Japan |
|---|---|---|
| Kunihiro Yamaoka | Department of Rheumatology and Infectious Diseases, Kitasato University School of Medicine |
ES9-1The Potential of IL-6 in Autoimmune Diseases from the Perspective of new imaging modality
| Speaker： | Georg Schett | Department of Internal Medicine 3 Rheumatology and Immunology, Friedrich Alexander University Erlangen-Nürnberg, Germany |
|---|
ES9-2The Role of IL-6 in the etiology of rheumatoid arthritis
| Speaker： | Satoshi Kubo | Department of Molecular Targeted Therapies, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan |
|---|---|---|
| Sponsored： | CHUGAI PHARMACEUTICAL CO., LTD. | |
ES 18
Treatment of Spondyloarthritis aiming for higher outcomes
April 19 (Fri) 17:40-19:10 Room 15 (2A Meeting Room, 2F, No.2 Building, Kobe International Exhibition Hall)
| Chair： | Shintaro Hirata | Hiroshima University Hospital |
|---|---|---|
| Hideto Kameda | Toho University |
ES18-1Treatment goal in the management of spondyloarthritis
| Speaker： | Yuko Kaneko | Keio University |
|---|
ES18-2Pathologic significance of IL-17A&F in the spondyloarthritis disease spectrum
| Speaker： | Iain B McInnes | University of Glasgow, UK |
|---|---|---|
| Sponsored： | UCB Japan Co. Ltd. | |
International Concurrent Workshop
April 18(Thu)
International Concurrent Workshop 1 Biomarkers 1
International Concurrent Workshop 2 Vasculitis 1
International Concurrent Workshop 3 Clinical study in RA 1
International Concurrent Workshop 4 Pathophysiology of RA 1
International Concurrent Workshop 5 bDMARDs for RA
International Concurrent Workshop 6 Clinical study in RA 2
International Concurrent Workshop 7 Biomarkers 2
International Concurrent Workshop 8 Biomarkers 3
International Concurrent Workshop 9 Clinical study in RA 3
International Concurrent Workshop 10 Antiphospholipid syndrome and Sjögren's syndrome
International Concurrent Workshop 11 Lupus nephritis
International Concurrent Workshop 12 Biologics for SLE
April 19(Fri)
International Concurrent Workshop 13 Basic 1
International Concurrent Workshop 14 Connective tissue diseases
International Concurrent Workshop 15 Autoinflammatory diseases
International Concurrent Workshop 16 Comorbidities
International Concurrent Workshop 17 JAK inhibitors for RA 1
International Concurrent Workshop 18 Inflammatory myopathies 1
International Concurrent Workshop 19 Biomarkers 4
International Concurrent Workshop 20 Infectious diseases
International Concurrent Workshop 21 Clinical study in SLE
International Concurrent Workshop 22 Inflammatory myopathies 2
International Concurrent Workshop 23 JAK inhibitors for RA 2
International Concurrent Workshop 24 Pathophysiology of RA 2
International Concurrent Workshop 25 Clinical study in Spondyloarthritis
International Concurrent Workshop 26 Clinical study in RA 4
International Concurrent Workshop 27 Osteoarthritis 1
April 20(Sat)
International Concurrent Workshop 28 Pathophysiology of Spondyloarthritis
International Concurrent Workshop 29 Vasculitis 2
International Concurrent Workshop 30 Basic 2
International Concurrent Workshop 31 JAK inhibitors for RA 3
International Concurrent Workshop 32 Systemic Sclerosis
International Concurrent Workshop 33 Pathophysiology of SLE
International Concurrent Workshop 34 Osteoarthritis 2
International Concurrent Workshop 35 Psoriatic arthritis
International Concurrent Workshop 36 Pathophysiology of RA 3
International Concurrent Workshop 37 Other rheumatic diseases
International Concurrent Workshop 38 Clinical study in RA 5
International Concurrent Workshop 39 Vasculitis 3
© 2023 The 68th Annual General Assembly and Scientific Meeting of the Japan College of Rheumatology